Campylobacter gracilis

   RANK: Species

TAXONOMY: Proteobacteria -> delta/epsilon subdivisions -> Epsilonproteobacteria -> Campylobacterales -> Campylobacteraceae -> Campylobacter -> Campylobacter gracilis

OVERVIEW:

In 1981, four species were recognized as comprising what had previously been called Bacteroides corrodens. one of these organisms was called Bacteroides gracilis, but based upon 16S rRNA analysis, the organism was transferred to the genus Campylobacter. Campylobacter gracilis is microaerophilic, but is stimulated on media containing formate and fumerate.Campylobacter gracilis is a common member of subgingival plaque. 16S rRNA cloning studies indicate that it is generally the most common oral Campylobacter species identified.Campylobactrer gracilis is a member of Socransky's Orange Complex and is associated with periodontal disease. It has been recoved from primary endodontic infections. It is occasionally isolated from systemic infections.Identified as a constituent of the oral microbiome by Human Oral Microbiome Database. Identified as constituent of vaginal microbiome. [PMID:23282177]

This species has been identified as a resident in the human gastrointestinal tract based on the phylogenetic framework of its small subunit ribosomal RNA gene sequences.[PMC 4262072]

2

COGEM
COGEM released a comprehensive database of pathogenicity assessment of around 2575 bacterial species in 2011. The database ranks the pathogenicity of species on a scale of 1 to 4. Campylobacter gracilis ranks 2 on this scale: Species that can cause diseases in humans or animals, which are unlikely to spread in the human population and for which an adequate prophylaxis or therapy exists


TAGS >
Keystone Core species Type species Pathogen Dysbiosis associated Flora/ commensal Gut associated Probiotic
Leanness Obesity Skin microbiome Fecal distribution Oral microbiome Vaginal microbiome Butyrate producer Catalase producer
Histamine producer Food fermenter Amylolytic Propionate producer Nitrifying Biofilm producer
INTERACTIONS
KEGG PATHWAYS

CLUSTERS WITH
METABOLOMICS       
NUTRIENTS/ SUBSTRATES

ENDPRODUCTS

INHIBITED BY

ENHANCED BY

BIOTRANSFORMS

BIOTRANFORM
ANTIBIOTIC RESISTANCE   BIOFILM FORMERS   COGEM PATHOGENICITY   

OPUS 23™ IS A REGISTERED TRADEMARK ® OF DATAPUNK BIOINFORMATICS, LLC. COPYRIGHT © 2015-2023. ALL RIGHTS RESERVED.     |